Article ID Journal Published Year Pages File Type
6006548 Clinical Neurology and Neurosurgery 2019 4 Pages PDF
Abstract
The use of progesterone may significantly improve neurologic outcome of patients suffering severe TBI up to 3 months after injury, especially those with 5 ≤ GCS ≤ 8, providing a potential benefit to the treatment of acute severe TBI patients. Considering this drug had no significant side effects, so progesterone could be used in patients with severe TBI as a neuro-protective drug.
Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , , , , , , , , ,